{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:38Z","timestamp":1740107738070,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI17C0966"],"award-info":[{"award-number":["HI17C0966"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["No.2016R1A2B4008376"],"award-info":[{"award-number":["No.2016R1A2B4008376"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10103-018-2692-5","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T16:55:02Z","timestamp":1543510502000},"page":"1019-1029","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Essential Role of mTOR Signaling in Human Retinal Pigment Epithelial Cell Regeneration After Laser Photocoagulation"],"prefix":"10.1007","volume":"34","author":[{"given":"Sanjar Batirovich","family":"Madrakhimov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Yan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-4384","authenticated-orcid":false,"given":"Tae Kwann","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"2692_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0161-6420(78)35693-1","volume":"85","author":"Diabetic Retinopathy Study Research Group","year":"1978","unstructured":"Diabetic Retinopathy Study Research Group (1978) Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings. Ophthalmology 85:82\u2013106. https:\/\/doi.org\/10.1016\/S0161-6420(78)35693-1","journal-title":"Ophthalmology"},{"key":"2692_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0161-6420(87)33527-4","volume":"94","author":"Early Treatment Diabetic Retinopathy Study research group","year":"1987","unstructured":"Early Treatment Diabetic Retinopathy Study research group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology 94:761\u2013774","journal-title":"Ophthalmology"},{"key":"2692_CR3","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group (2004) Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233\u2013248 discussion 248\u201350","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2692_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0002-9394(75)90613-3","volume":"79","author":"LA Priebe","year":"1975","unstructured":"Priebe LA, Cain CP, Welch AJ (1975) Temperature rise required for production of minimal lesions in the Macaca mulatta retina. Am J Ophthalmol 79:405\u2013413. https:\/\/doi.org\/10.1016\/0002-9394(75)90613-3","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"2692_CR5","doi-asserted-by":"publisher","first-page":"e70465","DOI":"10.1371\/journal.pone.0070465","volume":"8","author":"P Tababat-Khani","year":"2013","unstructured":"Tababat-Khani P, Berglund LM, Agardh CD, Gomez MF, Agardh E (2013) Photocoagulation of human retinal pigment epithelial cells in vitro: evaluation of necrosis, apoptosis, cell migration, cell proliferation and expression of tissue repairing and cytoprotective genes. PLoS One 8(8):e70465. https:\/\/doi.org\/10.1371\/journal.pone.0070465","journal-title":"PLoS One"},{"key":"2692_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H","volume":"184","author":"PA Campochiaro","year":"2000","unstructured":"Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184:301\u2013310. https:\/\/doi.org\/10.1002\/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H","journal-title":"J Cell Physiol"},{"issue":"4","key":"2692_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ajo.2003.11.015","volume":"137","author":"EJ Duh","year":"2004","unstructured":"Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M et al (2004) Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 137(4):668\u2013674. https:\/\/doi.org\/10.1016\/j.ajo.2003.11.015","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2692_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85(3):845\u2013881. https:\/\/doi.org\/10.1152\/physrev.00021.2004","journal-title":"Physiol Rev"},{"issue":"9","key":"2692_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2174\/156652410793937813","volume":"10","author":"JR Sparrrow","year":"2010","unstructured":"Sparrrow JR, Hicks D, Hamel CP (2010) The retinal pigment epithelium in health and disease. Curr Mol Med 10(9):802\u2013823. https:\/\/doi.org\/10.2174\/156652410793937813","journal-title":"Curr Mol Med"},{"issue":"9","key":"2692_CR10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1097\/IAE.0b013e318285cd9e","volume":"33","author":"PS Muether","year":"2013","unstructured":"Muether PS, Neuhann I, Buhl C, Hermann MM, Kirchhof B, Fauser S (2013) Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina 33(9):1809\u20131814. https:\/\/doi.org\/10.1097\/IAE.0b013e318285cd9e","journal-title":"Retina"},{"issue":"11","key":"2692_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1136\/bjo.2010.182162","volume":"94","author":"M Kernt","year":"2010","unstructured":"Kernt M, Neubauer AS, Liegl RG, Hirneiss C, Alge CS, Wolf A, Ulbig MW, Kampik A (2010) Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF. Br J Ophthalmol 94(11):1533\u20131539. https:\/\/doi.org\/10.1136\/bjo.2010.182162","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2692_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000088263","volume":"37","author":"LO Hattenbach","year":"2005","unstructured":"Hattenbach LO, Beck KF, Pfeilschifter J, Koch F, Ohrloff C, Schacke W (2005) Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells. Ophthalmic Res 37(6):341\u2013346. https:\/\/doi.org\/10.1159\/000088263","journal-title":"Ophthalmic Res"},{"issue":"2","key":"2692_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","volume":"142","author":"J Polivka Jr","year":"2014","unstructured":"Polivka J Jr, Janku F (2014) Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway. Pharmacol Ther 142(2):164\u2013175. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.004","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2692_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125(1):25\u201332. https:\/\/doi.org\/10.1172\/JCI73939","journal-title":"J Clin Invest"},{"issue":"1","key":"2692_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.12756","volume":"1346","author":"A Perl","year":"2015","unstructured":"Perl A (2015) mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci 1346(1):33\u201344. https:\/\/doi.org\/10.1111\/nyas.12756","journal-title":"Ann N Y Acad Sci"},{"issue":"7432","key":"2692_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature11861","volume":"493","author":"SC Johnson","year":"2013","unstructured":"Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493(7432):338\u2013345. https:\/\/doi.org\/10.1038\/nature11861","journal-title":"Nature"},{"issue":"2","key":"2692_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274\u2013293. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"issue":"3","key":"2692_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"L Jing","year":"2014","unstructured":"Jing L, Sang GK, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19(3):373\u2013379. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.001","journal-title":"Cell Metab"},{"issue":"4","key":"2692_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.18632\/aging.100303","volume":"3","author":"C Zhao","year":"2011","unstructured":"Zhao C, Vollrath D (2011) mTOR pathway activation in age-related retinal disease. Aging (Albany NY) 3(4):346\u2013347. https:\/\/doi.org\/10.18632\/aging.100303","journal-title":"Aging (Albany NY)"},{"key":"2692_CR20","doi-asserted-by":"crossref","first-page":"589813","DOI":"10.1155\/2011\/589813","volume":"2011","author":"JL Jacot","year":"2011","unstructured":"Jacot JL, Sherris D (2011) Potential therapeutic roles for inhibition of the PI3K\/Akt\/mTOR pathway in the pathophysiology of diabetic retinopathy. J Ophthalmol 2011:589813","journal-title":"J Ophthalmol"},{"issue":"11","key":"2692_CR21","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1248\/bpb.b14-00487","volume":"37","author":"R Yagasaki","year":"2014","unstructured":"Yagasaki R, Nakahara T, Ushikubo H, Mori A, Sakamoto K, Ishii K (2014) Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy. Biol Pharm Bull 37(11):1838\u20131842. https:\/\/doi.org\/10.1248\/bpb.b14-00487","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"2692_CR22","first-page":"97","volume":"35","author":"H \u00c7akmak","year":"2016","unstructured":"\u00c7akmak H, Ergin K, Bozkurt G, Kocat\u00fcrk T, Evli\u00e7o\u011flu GE (2016) The effects of topical everolimus and sunitinib on corneal neovascularization. Cutan Ocul Toxicol 35(2):97\u2013103","journal-title":"Cutan Ocul Toxicol"},{"issue":"6","key":"2692_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.exer.2010.03.002","volume":"90","author":"Z Faghiri","year":"2010","unstructured":"Faghiri Z, Bazan NG (2010) PI3K\/Akt and mTOR\/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp Eye Res 90(6):718\u2013725 https:\/\/doi.org\/10.1016\/j.exer.2010.03.002","journal-title":"Exp Eye Res"},{"key":"2692_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155\u2013169. https:\/\/doi.org\/10.1006\/exer.1996.0020","journal-title":"Exp Eye Res"},{"key":"2692_CR25","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1016\/S0021-9258(18)82319-5","volume":"268","author":"CP Hamel","year":"1993","unstructured":"Hamel CP, Tsilou E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM (1993) Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem 268:15751\u201315757","journal-title":"J Biol Chem"},{"key":"2692_CR26","doi-asserted-by":"publisher","first-page":"12932","DOI":"10.1073\/pnas.94.24.12932","volume":"94","author":"SC Finnemann","year":"1997","unstructured":"Finnemann SC, Bonilha VL, Marmorstein AD, RodriguezBoulan E (1997) Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. Proc Natl Acad Sci U S A 94:12932\u201312937. https:\/\/doi.org\/10.1073\/pnas.94.24.12932","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2692_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2017.05.012","volume":"8","author":"TK Park","year":"2017","unstructured":"Park TK, Lee SH, Choi JS, Nah SK, Kim HJ, Park HY, Lee H, Lee SHS, Park K (2017) Adeno-associated viral vector-mediated mTOR inhibition by short hairpin RNA suppresses laser-induced choroidal neovascularization. Mol Ther Nucleic Acids 8:26\u201335. https:\/\/doi.org\/10.1016\/j.omtn.2017.05.012","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"2692_CR28","first-page":"203","volume":"10","author":"JR Oh","year":"2017","unstructured":"Oh JR, Han JW, Kim YK, Ohn YH, Park TK (2017) The effects of anti-vascular endothelial growth factor agents on human retinal pigment epithelial cells under high glucose conditions. Int J Ophthalmol 10(2):203\u2013210","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"2692_CR29","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1007\/s11033-014-3321-4","volume":"41","author":"H Zong","year":"2014","unstructured":"Zong H, Yin B, Zhou H, Cai D, Ma B, Xiang Y (2014) Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition. Mol Biol Rep 41(7):4507\u20134512. https:\/\/doi.org\/10.1007\/s11033-014-3321-4","journal-title":"Mol Biol Rep"},{"issue":"8","key":"2692_CR30","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1007\/s13277-015-3315-4","volume":"36","author":"B Han","year":"2015","unstructured":"Han B, Cui H, Kang L, Zhang X, Jin Z, Lu L, Fan Z (2015) Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. Tumour Biol 36(8):6295\u20136304. https:\/\/doi.org\/10.1007\/s13277-015-3315-4","journal-title":"Tumour Biol"},{"issue":"2","key":"2692_CR31","doi-asserted-by":"publisher","first-page":"e88203","DOI":"10.1371\/journal.pone.0088203","volume":"9","author":"R Liegl","year":"2014","unstructured":"Liegl R, Koenig S, Siedlecki J, Haritoglou C, Kampik A, Kernt M (2014) Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expression. PLoS One 9(2):e88203. https:\/\/doi.org\/10.1371\/journal.pone.0088203","journal-title":"PLoS One"},{"issue":"6","key":"2692_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.embor.embor867","volume":"4","author":"MW Briggs","year":"2003","unstructured":"Briggs MW, Sacks DB (2003) IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep 4(6):571\u2013574. https:\/\/doi.org\/10.1038\/sj.embor.embor867","journal-title":"EMBO Rep"},{"issue":"Pt 10","key":"2692_CR33","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1242\/jcs.02379","volume":"118","author":"J Noritake","year":"2005","unstructured":"Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K (2005) IQGAP1: a key regulator of adhesion and migration. J Cell Sci 118(Pt 10):2085\u20132092. https:\/\/doi.org\/10.1242\/jcs.02379","journal-title":"J Cell Sci"},{"issue":"Pt 12","key":"2692_CR34","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1242\/jcs.044644","volume":"122","author":"JB Wang","year":"2009","unstructured":"Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA (2009) IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci 122(Pt 12):2024\u20132033. https:\/\/doi.org\/10.1242\/jcs.044644","journal-title":"J Cell Sci"},{"key":"2692_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/bs.ctdb.2014.11.018","volume":"112","author":"PD McCrea","year":"2015","unstructured":"McCrea PD, Maher MT, Gottardi CJ (2015) Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol 112:129\u2013196. https:\/\/doi.org\/10.1016\/bs.ctdb.2014.11.018","journal-title":"Curr Top Dev Biol"},{"issue":"6","key":"2692_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420\u20131428. https:\/\/doi.org\/10.1172\/JCI39104","journal-title":"J Clin Invest"},{"issue":"5","key":"2692_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1006\/exer.1997.0374","volume":"65","author":"BS McKay","year":"1997","unstructured":"McKay BS, Irving PE, Skumatz CM, Burke JM (1997) Cell-cell adhesion molecules and the development of an epithelial phenotype in cultured human retinal pigment epithelial cells. Exp Eye Res 65(5):661\u2013671. https:\/\/doi.org\/10.1006\/exer.1997.0374","journal-title":"Exp Eye Res"},{"issue":"6","key":"2692_CR38","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1167\/iovs.05-1335","volume":"47","author":"YH Youn","year":"2006","unstructured":"Youn YH, Hong J, Burke JM (2006) Cell phenotype in normal epithelial cell lines with high endogenous N-cadherin: comparison of RPE to an MDCK subclone. Invest Ophthalmol Vis Sci 47(6):2675\u20132685. https:\/\/doi.org\/10.1167\/iovs.05-1335","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2692_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/iub.1382","volume":"67","author":"NN Liu","year":"2015","unstructured":"Liu NN, Zhao N, Cai N (2015) Suppression of the proliferation of hypoxia-induced retinal pigment epithelial cell by rapamycin through the \/mTOR\/HIF-1\u03b1\/VEGF\/ signaling. IUBMB Life 67(6):446\u2013452. https:\/\/doi.org\/10.1002\/iub.1382","journal-title":"IUBMB Life"},{"issue":"5","key":"2692_CR40","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","volume":"69","author":"J Copp","year":"2009","unstructured":"Copp J, Manning G, Hunter T (2009) TORC-specific phosphorylation of mTOR: phospho-Ser2481 is a marker for intact mTOR-C2. Cancer Res 69(5):1821\u20131827. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3014","journal-title":"Cancer Res"},{"issue":"2","key":"2692_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell 22(2):159\u2013168. https:\/\/doi.org\/10.1016\/j.molcel.2006.03.029","journal-title":"Mol Cell"},{"issue":"8","key":"2692_CR42","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/MCB.24.8.3112-3124.2004","volume":"24","author":"M Pende","year":"2004","unstructured":"Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC, Thomas G (2004) S6K1(-\/-)\/S6K2(-\/-) mice exhibit perinatal lethality and rapamycin-sensitive 5\u2032-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24(8):3112\u20133124. https:\/\/doi.org\/10.1128\/MCB.24.8.3112-3124.2004","journal-title":"Mol Cell Biol"},{"issue":"34","key":"2692_CR43","doi-asserted-by":"publisher","first-page":"56698","DOI":"10.18632\/oncotarget.18082","volume":"8","author":"DE Butler","year":"2017","unstructured":"Butler DE, Marlein C, Walker HF et al (2017) Inhibition of the PI3K\/AKT\/mTOR pathway activates autophagy and compensatory Ras\/Raf\/MEK\/ERK signalling in prostate cancer. Oncotarget 8(34):56698\u201356713. https:\/\/doi.org\/10.18632\/oncotarget.18082","journal-title":"Oncotarget"},{"issue":"11","key":"2692_CR44","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.ophtha.2016.07.029","volume":"123","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S et al (2016) Intravitreal Sirolimus for noninfectious uveitis: a phase III Sirolimus study Assessing double-masKed Uveitis TReAtment (SAKURA). Ophthalmology 123(11):2413\u20132423. https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.029","journal-title":"Ophthalmology"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-018-2692-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10103-018-2692-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-018-2692-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T18:41:49Z","timestamp":1694112109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10103-018-2692-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1007\/s10103-018-2692-5","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"type":"print","value":"0268-8921"},{"type":"electronic","value":"1435-604X"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}